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Abstract
The roles of bacterial RecA in the evolution and transmission of antibiotic resistance genes make it
an attractive target for inhibition by small molecules. We report two complementary fluorescence-
based ATPase assays that were used to screen for inhibitors of RecA. We elected to employ the ADP-
linked variation of the assay, with a Z′ factor of 0.83 in 96-well microplates, to assess whether 18
select compounds could inhibit ATP hydrolyis by RecA. The compounds represented five sets of
related inhibitor scaffolds, each of which had the potential to cross-inhibit RecA. Although nucleotide
analogs, known inhibitors of GHL ATPases, and known protein kinase inhibitors were not active
against RecA, we found that three suramin-like agents substantially inhibited RecA's ATPase
activity.
Drug resistance is an ever-increasing problem in the chemotherapy of bacterial infectious
diseases. The de novo development and clonal spread of drug-resistant bacteria, and the
horizontal transfer of resistance factors among bacteria have resulted in a dramatic increase in
the incidence of drug-resistant infections. One strategy to improve the efficacy of existing
antibacterial drugs involves countering bacterial mechanisms of drug resistance. In this context,
RecA has emerged as a potential target because its activities allow bacteria to overcome the
metabolic stress induced by a range of antibacterial agents, and promote the de novo
development and transmission of antibiotic resistance genes.1-5 Although potent and selective
inhibitors of RecA could be used to modulate its activities in the development of antibiotic
resistance, no small-molecule natural product inhibitor of RecA's activities has been reported.
Herein, we report two rapid, microvolume molecular screening assays and their
implementation in the directed screening of prospective inhibitors of RecA's ATPase activity.
We have previously demonstrated that select NDP and NTP analogs inhibit RecA ATP
hydrolysis.6,7 Because nucleotide analogs are largely unsuited for use in cell-based assays, we
screened a small, focused set of commercially available compounds to discover non-nucleotide
inhibitors of RecA. The compounds we elected to study can be ordered in five groups (Figure
1). The first group comprises vanillin,8,9 cinnamaldehyde,9 curcumin,10 and the soy-derived
compounds genistin and genistein,11 all of which may inhibit RecA based on their activities
in microbiological assays. The second group includes adenosine nucleotide-like
compounds12,13 that may extend upon our previous success with ADP analogs. The third
group is composed of inhibitors of the gyrase-Hsp90-like (GHL) family of ATPases.14,15 The
fourth group includes adenine-like inhibitors of protein kinases.16 The fifth group comprises
compounds related to the non-nucleotide inhibitors of purine nucleotide receptors, suramin and
PPADS.17,18
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High-throughput screening is a useful method for the identification of novel inhibitory
scaffolds. Recently, we reported a coupled enzyme assay that was optimized for determination
of E. coli RecA's ssDNA-dependent ATPase activity, which is a useful indicator of active
RecA-DNA filament assembly.7 It was undesirable to use this assay to screen a larger, more
diverse library because many of the compounds may be UV active at 360 nm. This interfering
absorbance would lead to false negatives in a high-throughput screening project.
To address this concern, we developed two robust and reproducible microplate assays for
RecA's ATPase activity that are suitable for screening collections of small molecules as
prospective RecA inhibitors without the potential for signal interference generated by UV-
active compounds (Figure 2). Each variation of the assay utilizes one product of ATP
hydrolysis, either ADP or Pi, as a substrate for commercially available enzymes and, for every
molecule of ATP hydrolyzed by RecA, one molecule of amplex red is ultimately oxidized to
resorufin, which has a unique fluorescence emission at 595 nm.19 In one variant of the assay,
Pi and inosine serve as substrates for PNP in the production of hypoxanthine and ribose-1-
phosphate. In turn, the O2-dependent oxidation of hypoxanthine by xanthine oxidase produces
uric acid and H2O2, the latter of which is used by horseradish peroxidase to oxidize amplex
red to resorufin. In the other assay variant, ADP and phosphoenolpyruvate serve as substrates
for the commercially available enzyme pyruvate kinase to produce ATP and pyruvate, the latter
of which is a substrate for O2-dependent oxidization by pyruvate oxidase in the production of
acetylphosphate and H2O2.20 Identical to the first assay, horseradish peroxidase uses H2O2 to
catalyze the oxidation of amplex red to resorufin.
To determine if these assays were suitable for high-throughput screening, we assessed their
robustness and reproducibility using a statistical analysis.21 In our hands, the ADP-linked
ATPase assay was more useful as a screening assay because the Pi-linked assay was sensitive
to variations in the residual phosphate contaminating enzyme and DNA preparations. For the
ADP-linked ATPase assay optimized for 96-well microplates,22 positive and negative control
experiments were performed on three different days with 48 wells per condition to simulate
the day-to-day and well-to-well variability between assays (Figure 3). Statistical evaluation of
the results yielded a reproducible Z′ factor of 0.83, demonstrating the excellent utility of the
assay for reproducibly differentiating normal activity from inhibition. Furthermore, the
inclusion of the two most potent NTP-analog inhibitors discovered in our previous work7
verified that known RecA ATPase inhibitors would prevent resorufin production using this
assay system (Figure 3).
With a suitable ATPase assay in hand, we assessed the abilities of the 18 compounds in our
directed mini-library (Figure 1) to inhibit RecA's ATPase activity at 100 μM. The fractional
inhibition observed in the presence of each compound was obtained by comparing the total
fluorescence in wells containing the reaction in the presence and absence of inhibitor (Figure
4). Only curcumin from Group 1 and the polysulfated naphthyl compounds suramin, Congo
Red and bis-ANS, from Group 5, appeared to inhibit RecA's ATPase activity under these
conditions.
Upon the identification of molecules that attenuated resorufin production, it was necessary to
determine whether these compounds were selectively inhibiting RecA or other components of
the coupled assay system. Therefore, four compounds were evaluated in subsequent control
reactions in the presence of 500 μM ADP, but in the absence of RecA. Because all four of these
compounds also inhibited pyruvate kinase in the control assay, we evaluated their abilities to
inhibit RecA's ATPase activity using the Pi-linked fluorescence ATPase assay described above.
Suramin, Congo Red, and bis-ANS, but not curcumin, inhibited ATP hydrolysis by RecA.
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It is important to note that none of the compounds expected to inhibit RecA based on prior
biological activity studies (Group 1) inhibited RecA's ATPase activity in vitro. Possible
explanations for the apparent inconsistency include the following: (1) these compounds may
inhibit RecA-associated proteins rather than RecA itself; or (2) these compounds may interfere
with RNA or protein synthesis. Of additional importance is the observation that no known
inhibitor from Group 2, 3 or 4 substantially inhibited RecA's ATPase activity. The failure to
discover a RecA inhibitor among these compounds suggests that the development of a potent
RecA inhibitor will not be a trivial exercise. However, the same lack of cross-inhibition of
RecA by known inhibitors of other ATP-dependent enzymes also suggests the likelihood of
ultimately discovering specific inhibitors of RecA's activities.
Although we did not observe inhibition of RecA by any of the molecules in Groups 1, 2, 3, or
4, we did find that the polysulfated naphthyl compounds Congo Red, suramin, and bis-ANS
strongly inhibited the ATPase activity of RecA. The nature of the inhibition by these
compounds is reputed to be promiscuous. Indeed, it has been established that, in aqueous
solution, Congo Red self-assembles into supramolecular aggregates23,24 that can result in
apparent inhibition by the reversible sequestration of enzyme.25,26 In contrast, suramin, which
is also active against many different enzymes27 and is structurally similar to Congo Red, does
not form aggregates and does not inhibit model enzymes that are sensitive to supramolecular
ligands.25,26 The possibility that suramin may be a structure- or mechanism-specific inhibitor
of RecA is supported by the observation that PPADS does not inhibit RecA's ATPase activity,
despite the fact that both compounds are potent antagonists of the P2X1 nucleotide receptors.
18 Finally, it is noteworthy that select transition metal cations trap inactive RecA as insoluble
aggregates,28 but no visible precipitates were formed in the presence of suramin, Congo Red,
or bis-ANS.
To probe this class of polysulfated naphthyl compounds further, we characterized the nature
of the inhibition of RecA by suramin. While suramin inhibited RecA's ATPase activity with
an IC50 of approximately 2 μM, the inhibition was not competitive with respect to ATP or
ssDNA binding (data not shown). We speculate that suramin modulates RecA's activity by
binding to an allosteric region of the protein and trapping the protein in its inactive
conformation (Figure 5).
Importantly, we demonstrated that suramin interferes with the RecA-mediated DNA strand
exchange reaction, an established RecA activity that serves as an in vitro model for its
physiologic recombinational functions.29 It is known that RecA must hydrolyze ATP in order
to carry out the strand exchange reaction between ϕχ174 cssDNA and homologous, linear
dsDNA (S) to yield a nicked circular dsDNA product (P), which migrates more slowly under
electrophoretic conditions than the substrate DNA molecules. The presence of suramin (100
μM) in this reaction completely abrogated the formation of nicked circular dsDNA product,
even over the course of 90 min (Figure 6).
In conclusion, we have reported two new fluorescence-based assays for screening potential
inhibitors of RecA's ATPase activity. We previously developed activity assays for RecA's
ATPase and filament assembly activities,6,7 and the new molecular screening assays
complement and extend the previous assays by providing an observable parameter that is not
influenced adversely by UV-active compounds. Moreover, the assays reported herein were
optimized for use with RecA based on its production of either free phosphate or ADP. We
further reported that suramin, Congo Red, and bis-ANS strongly inhibit RecA's ATPase assay
and compose a new structural class of RecA inhibitors. We expect that polysulfated naphthyl
compounds such as these are likely to be of little therapeutic utility due to membrane-
impermeability caused by their negative charges. Nonetheless these compounds may be used
in future rational modification procedures for the synthesis microbiological tools to tease apart
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the roles of RecA in various aspects of pathogenicity. We envision that such inhibitors may
ultimately be developed into novel adjuvants for antibiotic chemotherapy that moderate the
development and transmission of antibiotic resistance genes and increase the antibiotic
therapeutic index.
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Five classes of compounds screened for RecA inhibition.
Wigle and Singleton Page 6














Two fluorescent ATPase assay schemes used to monitor ATP hydrolysis by RecA .
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Interday and intercolumn precision for the ADP-linked fluorescent ATPase assay.
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Results of the directed screen of 18 selected compounds against RecA ATP hydrolysis activity.
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Cartoons depicting the inactive and active conformation of RecA filaments and the roles of the
latter in the de novo development and transmission of antibiotic resistance (AR) genes.
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Suramin inhibits the RecA-mediated DNA three strand exchange reaction.
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